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The strategies of the Theileria parasite: a new twist in
host–pathogen interactions
Dirk AE Dobbelaere1 and Peter Ku¨enzi2
Theileria parasites infect and transform cells of the ruminant
immune system. Continuous proliferation and survival of
Theileria-transformed cells involves the well-orchestrated
activation of several host-cell signalling pathways. Constitutive
NF-kB (nuclear factor kappaB) activation is accomplished
by recruiting the IKK (IkB kinase) complex, a central regulator of
NF-kB pathways, to the surface of the transforming schizont,
where it becomes permanently activated. Constitutive activation
of the PI-3K–PKB [phosphoinositide 3-kinase–(Akt) protein
kinase B] pathway is likely to be indirect and is essential for
continuous proliferation. Theileria-transformed T cells express a
range of anti-apoptotic proteins that can be expected to provide
protection against apoptosis induced by death receptors, as
well as cellular control mechanisms that are mobilised to
eliminate cells that entered a cycle of uncontrolled proliferation.
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Abbreviations
FLIP FLICE (Fas-associated death domain protein-like
interluekin-1b-converting enzyme) inhibitory protein
IAP inhibitor of apoptosis protein
IKK IkB Kinase
IjB inhibitory NF-kB
IL interleukin
JNK c-Jun NH2-terminal kinase
MKK mitogen-activated protein kinase kinase
NF-jB nuclear factor kappaB
PI-3K phosphoinositide 3-kinase
PKB (Akt) protein kinase B
PTEN phosphatase and tensin homolog deleted on chromosome 10
TNF tumour necrosis factor
TRAF TNF-receptor-associated factor
Introduction
Protozoan Theileria parasites are transmitted by ticks and
cause severe diseases in ruminants (predominantly cattle,
but also sheep and goat), inﬂicting heavy economic losses
to livestock producers in the affected regions. Theileria
sporozoites, introduced with the tick saliva as the tick
takes a blood meal, rapidly invade leukocytes via recep-
tors that have not yet been identiﬁed [1]. Shortly after
entry, the enveloping host cell membrane is eliminated
and the parasite develops into a schizont, which, by
contrast to most apicomplexan parasites, resides freely
in the host cell cytoplasm rather than in a parasitophorous
vacuole. This way, the parasite escapes lysosomal
destruction and, from its cytoplasmic location, the schi-
zont is perfectly poised to interfere with host cell signal-
ling pathways that regulate host cell proliferation and
survival. The capacity of the schizont to trigger the
uncontrolled proliferation of the infected cell is closely
associated with the pronounced pathology and mortality
that is caused by Theileria infections. In many ways,
Theileria-transformed cells resemble tumour cells; they
become independent of exogenous growth factors, can be
cloned by limiting dilution, form tumours in immuno-
compromised mice and acquire a metastatic phenotype
that allows parasitized cells to invade and multiply in
non-lymphoid as well as lymphoid tissues (reviewed in
[2]). One striking difference between these cells and
tumour cells is that transformation is entirely reversible.
Upon killing of the parasite by treatment with the
naphthoquinone derivative BW720c, cell proliferation
is halted and, in the case of T cells, exogenous growth
factors need to be added to prevent apoptosis of the cured
cells [3]. Parasite multiplication appears to be semi-
synchronized with the host cell cycle [4] and the tight
association of the schizont with the host cell mitotic
apparatus ensures the distribution of the schizont over
the daughter cells (Figure 1). Theileria parva, Theileria
annulata, Theileria lestoquardi and Theileria taurotragi infect
and transform cells of the immune system. T. parva
transforms T cells and B cells, whereas T. annulatamainly
transforms B cells and cells of monocyte or macrophage
lineage. The cells targeted by T. lestoquardi (a parasite of
small ruminants) and T. taurotragi (a parasite of water-
buck) have not yet been characterised in detail.
At ﬁrst sight, seeking refuge in those cells that are
normally recruited to destroy invading organisms might
appear cunning. Inducing uncontrolled host cell prolif-
eration, however, is nothing less than foolhardy, partic-
ularly when we consider the fact that immune cells are
subject to stringent control mechanisms, with apoptosis
frequently used as a lethal device to prevent uncontrolled
expansion. This review focuses on how recent ﬁndings
could help to explain the complex phenotypic changes
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that accompany Theileria-induced transformation and
some models are presented on how parasite-transformed
cells escape apoptosis.
Signalling pathways that are activated in
Theileria-transformed cells
With the exception of interleukin (IL)-10, which is
expressed in all Theileria-transformed cell lines tested,
there is considerable variation in the pattern of cytokine
expression [5]. This would suggest that different signal-
ling pathways are activated, depending on the cell type
that is infected. An in vitro analysis of different cell lines,
however, reveals a remarkably similar pattern of signal
pathway activation. Thus, members of the src family of
protein kinases appear to be activated in all cell lines
[6,7,8], and so is casein kinase 2 [9], a kinase with a broad
spectrum of substrates. Three additional pathways will be
discussed in more detail in the following sections.
Mitogen activated protein kinases (MAPKs)
MAPKs form part of some of the most ancient signalling
pathways and are involved in virtually all aspects of
immune responses [10]. It was therefore surprising that,
of the three major groups, the extracellular signal-
regulated protein kinases (ERKs), the p38 MAPKs and
the c-Jun NH2-terminal kinases (JNKs), only the JNKs
were found to be activated [11,12]. This was even more
unexpected, because ERK activation has been linked to
cell proliferation, whereas JNK (and also p38) is generally
associated with the induction of apoptosis. JNK and its
cellular substrate c-Jun play an active role in apoptosis; in
particular, in Fas-mediated cell death. They regulate
FasL expression, repress anti-apoptotic Bcl-2-family pro-
teins, and induce the upregulation of the proapoptotic
Bcl-2-family protein BIM (reviewed in [10,13]); however,
JNK and c-Jun have also been linked to proliferation.
C-Jun is essential for embryonic development and also for
normal cell proliferation—mouse embryo ﬁbroblasts that
are deﬁcient for c-Jun show a senescence-like growth
arrest in vitro. Linking c-Jun to transformation, MEFs
(mouse embryo ﬁbroblats) are resistant to transformation
by the Ras oncogene in the absence of c-Jun, and the
virally encoded v-Jun is involved in tumourigenesis [13].
It is therefore conceivable that JNK, by inducing per-
manent activation of the transcription factors AP1 and
ATF-2 in Theileria-transformed cells [12,14], also contrib-
utes to their uncontrolled proliferation.
Constitutive NF-jB activation
The fact that a potentially lethal pair such as JNK and
c-Jun is functional in Theileria-transformed cells implies
that the cell must have erected a solid line of defence
against apoptosis. NF-kB is constitutively activated in
Theileria-transformed cells [15,16] and protects T. parva-
transformed T cells from apoptosis [17]. NF-kB activa-
tion is normally triggered through a range of different
surface receptors or intracellular events, including cellular
stress. These pathways all converge onto a multi-subunit
kinase complex, called IKK [IkB (inhibitory NF-kB)
kinase] [18]. This complex typically consists of two
catalytic subunits, IKK1 (IKKa) and IKK2 (IKKb), and
a modulating unit NEMO (NF-kB essential modulator;
IKKg). NF-kB is sequestered in the cytoplasm by inhi-
bitors (IkBs) that are phosphorylated by activated IKK,
tagging them for polyubiquitination and rapid protea-
somal degradation. This allows the released NF-kB to
translocate to the nucleus, where it participates in reg-
ulating the expression of a range of genes that are
involved in immune and inﬂammatory responses [19],
proliferation [20] and survival [21].
Electrophoretic mobility shift and UV-crosslinking assays
that have been performed on T. parva-transformed T
cells have revealed the abundant presence of p50, p65 and
also RelB; p52 and c-Rel, however, were not apparent
[22]. The absence of p52 DNA-binding activity indicates
that the non-canonical NIK (NF-kB-inducing kinase)/
IKK1-dependent NF-kB pathway is not active in T.
parva-transformed T cells. C-Rel is crucial for IL-2
expression in T cells and the absence of both c-Rel
and ERK activation in T. parva-transformed T cells helps
to explain the low level of IL-2 gene transcription [2].
Using digital confocal microscopy, it has been demon-
strated that the parasite induces constitutive NF-kB
activation by a novel mechanism, involving the recruit-
ment of large aggregates of IKK signalosomes to its
surface [23]. IKK activation, triggered by pro-inﬂam-
matory mediators such as TNF (tumour necrosis factor)-a
and IL-1, requires the concerted action of upstream
adaptor proteins such as TRAFs [TNF-receptor (TNF-
R)-associated factors], as well as a range of kinases and
other regulatory molecules, but the involvement of
such upstream components in parasite-induced NF-kB
Figure 1
Dividing T. annulata-transformed cells. During host cell division, the
parasite uses the host cell mitotic apparatus to become distributed
over the two daughter cells. The T. annulata schizont is visualized
using an antibody directed against the surface proteins PIM
(green; kind gift from J Ahmed, Borstel). Host cell microtubules are
stained using an anti-a-tubulin antibody (red); nuclei are stained
blue with Hoechst-dye.
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activation appears to be excluded. Interestingly, this also
included RIP2, a kinase with an important function in
innate and adaptive immunity and NF-kB activation in
response to intracellular bacteria [24]. Direct interference
with the IKK complex or the phosphorylation of its
substrate IkBa, however, blocked parasite-induced NF-
kB activation, and functional IKK2 rather than IKK1
proved to be important. The lack of IKK1 involvement
is in agreement with the absence of p52 DNA-binding
activity in T. parva-transformed T cells. The NF-kB
activation pathway that emanates from the T cell antigen
receptor has recently been elucidated in more detail,
revealing an important role for CARMA1 (CARD-
MAGUK; Caspase recruitment domain -containing
membrane-associated guanylate kinase), MALT1
(mucosa-associated lymphoid tissue lymphoma transloca-
tion protein 1), Bcl10 and PKCy (reviewed in [25]).
Interestingly, overexpression of dominant-negative
mutant forms of CARMA1, Bcl10 and PKCy, all failed
to interfere with parasite-induced NF-kB activation in
T. parva-transformed T cells. Likewise, the tumour sup-
pressor cylindromatosis protein, CYLD, which functions
as a deubiquitinating enzyme and downregulates TRAF-
dependent IKK activation [26], also failed to block para-
site-induced NF-kB activation when overexpressed in
T. parva-transformed T cells (C Casanova, S Rottenberg
and DD, in preparation). Taken together, these ﬁndings
strongly indicate that Theileria bypasses the common
upstream regulatory components that link surface recep-
tors to IKK activation. The enforced oligomerisation of
IKK components at the parasite surface probably triggers
trans-autophosporylation and activation of IKK in a pro-
cess known as ‘proximity-induced activation’ [19,27].
It is worth noting that the direct, parasite-induced IKK
activation that is observed in the cell lines investigated by
Heussler and colleagues [23] does not necessarily
exclude a contribution of classical NF-kB activation
mechanism to the permanently elevated NF-kB activity
in other Theileria-transformed cell lines. In this context,
Guergnon et al. [28] recently reported that a TNFa auto-
crine loop might contribute, at least in part, to NF-kB
activation in a T. parva-transformed B cell line. Compa-
tible with the presence of a parasite-induced direct mode
of activation, however, blocking TNFa binding, or TNF-
R signalling by overexpression of dn-TRAF2, failed to
block NF-kB activity by more than 50%.
The PI-3K pathway
Of the multiple pathways that control cell proliferation
and survival, phosphoinositide kinases occupy a central
position. PI-3Ks are recruited to the plasma membrane in
response to triggers that are delivered by a wide range of
stimuli, including growth factors, immune receptors and
extracellular matrix components. PI-3K stimulation
results in activation of the serine/threonine kinase Akt
(also called PKB), which, in addition to regulating glucose
metabolism, also contributes to cell-cycle regulation and
protection against apoptosis (reviewed in [29]). PI-3K is
continuously activated in Theileria-transformed cells
[30–32], inducing PKB activation [32]. Blocking the PI-
3K–PKB pathway resulted in proliferation arrest without
inducing immediate apoptosis, indicating a role in the
support of proliferation rather than cell survival. In several
systems, evidence has been presented for PKB-
dependent IKK activation (summarized in [33]). In
T. parva-transformed T cells, a role for the PI-3K–PKB
pathway in parasite-induced constitutive NF-kB activa-
tion has been excluded [23]. Also, upon parasite elim-
ination, the PI-3K–PKB pathway is downregulated with
much slower kinetics than the NF-kB pathway, arguing
against a direct control by the parasite. The hypothesis we
presently favour is that PI-3K is activated indirectly
through one or more surface receptors or adhesion mole-
cules that are upregulated in Theileria-transformed cells.
Signals emanating from such surface receptors might
persist for some time after the parasite has been elimi-
nated and it cannot be excluded that some of these
surface molecules — or their ligands — are expressed
in a NF-kB-dependent manner, as proposed by Baum-
gartner and co-workers [31]. IL-10, which is expressed in
all T. parva-transformed cell lines, could qualify as a
candidate and, in this context, it is interesting that
IL-10 stimulation of PI-3K and p70S6K has been shown
to account for the proliferative, but not the anti-
inﬂammatory effects of IL-10 [34].
Theileria-transformed cells: a decided
preference for staying alive
Stimulation of FasL gene transcription by JNK via c-Jun
in response to a range of stress signals can contribute to
the induction of cell death in many different cell types
(reviewed in [13]). In addition to c-Jun, NF-kB also
participates in regulating the expression of both FasL
[35–37] and Fas [38,39]. Not unexpectedly, both Fas and
FasL are expressed inT. parva-transformedT cells [40],
but pronounced susceptibility to Fas/FasL-induced
apoptosis only appears upon drug-induced elimination
of the parasite. In normal T cells, the sensitivity to death-
receptor killing is regulated by speciﬁc inhibitor proteins,
several of which are regulated by NF-kB. The anti-
apoptotic protein c-FLIP [FLICE (Fas-associated death
domain protein-like interluekin-1b-converting enzyme)
inhibitory protein) functions as a catalytically inactive
form of caspase-8 and blocks Fas-mediated activation-
induced cell death (AICD) [41]. In addition to c-FLIP,
c-IAP and X chromosome-linked IAP (which block
downstream executioner caspases) are constitutively
expressed in T. parva-transformed T cells. They are
rapidly downregulated upon parasite elimination and
this coincides with increased caspase activity and apop-
tosis. Interestingly, in contrast to ﬁndings in tumour cell
lines, a functional PI-3K–Akt pathway is not essential for
c-FLIP expression [40]. To what extent Fas/FasL
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expression plays a role in the extensive lytic processes
that accompany Theileriosis is not known. Although T.
parva-infected B and T cells express TNF receptors,
TNFa does not induce apoptosis [28,42]. A logical expla-
nation could be that NF-kB-dependent upregulation of
anti-apoptotic proteins also provides protection against
TNF-induced apoptosis. A model for how Theileria-
transformed cells achieve protection against apoptosis
is summarized in Figure 2.
Additional mechanisms of defence against apoptosis may
be functional in Theileria-transformed cells. NF-kB has
been shown to induce the expression of Gadd45b (also
called MyD118) [43], which blocks MKK (mitogen-
activated protein kinase kinase)7/JNKK2, an essential
JNK activator, preventing TNFa-induced apoptosis
[44]. Likewise, NF-kB-dependent Gadd45b expres-
sion, induced through CD40, protects B cells against
Fas-mediated apoptosis [45]. The exact role of
Gadd45b in the crosstalk between NF-kB and JNK has
not yet been resolved (discussed in [21]). In Theileria-
transformed cells, JNK is clearly induced in a parasite-
dependent manner, despite constitutive NF-kB activa-
tion [11]. JNK activity is not maximal, however, and can
be induced further by phorphol ester stimulation. It will
be interesting to ascertain whether the function of
Gadd45b in T. parva-transformed cells is to keep levels
of JNK under control, allowing promotion of proliferation
without endangering survival, and to determine how this
balance is maintained. Whatever the case, although JNK
may have the reputation of ‘a killer on a transcriptional
leash’ [46], it appears to be less of a threat in Theileria-
transformed cells.
The exact role of NF-kB in regulating the expression of
the anti-apoptotic Bcl-2 family proteins, such as Bcl-2 and
Bcl-xL, is still under debate [47]. Both are expressed in
T. parva-transformed cells, but do not appear to be tightly
regulated by the presence of the parasite [40,48]. Bcl-2
was reported to protect T cells from ‘activated T cell
Figure 2
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Simplified model, depicting how Theileria-transformed cells are protected against apoptosis. The Theileria schizont induces constitutive NF-kB
activation by recruiting the IKK complex to its surface. At the schizont surface, IKK is activated and induces the phosphorylation and
subsequent proteasomal degradation of IkBa, the cytoplasmic inhibitor of NF-kB. In the nucleus, NF-kB, together with other transcription
factors, induces the expression of anti-apoptotic proteins, such as c-FLIP, XIAP, c-IAP1/2 and potentially also Bcl-2 and Bcl-XL. These can
provide protection against apoptosis at different levels. For instance, c-FLIP could block the processing of procaspase 8/10, triggered upon
ligand-induced activation of death receptors (e.g. Fas). IAPs counter effector caspases, and pro-survival proteins of the Bcl-2 family prevent
mitochondria-initiated apoptosis, by regulating cytochrome C release. APAF-1, apoptotic protease activating factor 1.
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autonomous death’ (ACAD), a form of T-cell death that
is distinguishable from that driven by death receptors
(reviewed in [49]). Bcl-2 also counters apoptotic pathways
induced by cellular stress that involve mitochondria and
caspase-9 activation. Caspase-9 and caspase-3 are acti-
vated upon elimination of the parasite from Theileria-
transformed T and B cell lines [40,48], but to what
extent Bcl-2 family members contribute to protection
has not yet been established.
Finally, NF-kB also interferes with pro-apoptotic path-
ways that are linked to the tumour suppressor protein
PTEN (phosphatase and tensin homolog deleted on
chromosome 10). PTEN possesses lipid and protein
phosphatase activity and acts as a negative regulator of
the PI-3K–PKB pathway [29]. Suppression of PTEN
expression by NF-kB [50] relies on the sequestration of
limiting pools of the transcriptional coactivator CBP
(cAMP response element binding protein, binding pro-
tein)/p300 by p65 rather than p65 transcriptional activity.
Perhaps, in Theileria-transformed cells, constitutive IkB
degradation [16] and p65 release helps to facilitate PI-3K
activation.
Conclusions
Theileria-transformed cells provide a fascinating example
of how pathogen interference with host-cell signal trans-
duction results in the reprogramming of the host cell
phenotype. A summary of the main features is presented
in Figure 3. The capacity of pathogens to transform
eukaryotic cells is largely restricted to viruses. The sim-
ilarities between the strategies used by Theileria and
HTLV-1 are striking [51]. These include constitutive
JNK and ATF-2 activity, as well as permanent NF-kB
activation via the direct stimulation of the IKK complex.
The exact mechanism by which the parasite recruits IKK
complexes to its surface is still unknown, but the failure to
identify parasite proteins that interact directly with IKK
components indicates that additional host cell proteins
may be involved. The ‘patchy’ accumulation of IKK
complexes on the parasite surface argues against an
interaction with a parasite surface molecule that is evenly
expressed on the schizont surface, and could reﬂect
clustering in the parasite plasma membrane, induced
by the multimeric IKK complexes. Alternatively, IKK
transport could rely on host-cell cytoskeletal components
and accumulation only occurs at sites where the cytoske-
leton interacts with the parasite surface.
Many open questions remain. The advent of RNAi
technology, in particular in combination with inducible
systems, should enable us to determine the precise con-
tribution of individual host cell proteins to the transfor-
mation process and protection against apoptosis. The
genomes of T. annulata and T. parva have now been
sequenced and annotated, opening up the search for
candidate transforming-parasite genes. In this context,
a comparison with the genome of a non-transforming
Figure 3
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Host-cell signal transduction pathways that are constitutively activated in Theileria-transformed cells. JNK is the only MAPK that is permanently
activated and appears to be responsible for AP-1 and ATF-2 activation. Different members of the Src-related kinase family are active, depending
on the cell type that is transformed, and can participate in signalling pathways emanating from different surface receptors. Casein kinase 2,
which has a multitude of different substrates, is strongly upregulated. The NF-kB pathway is activated directly by the parasite through the
recruitment and activation of IKK complexes at the schizont surface. Input from other pathways, however, might also contribute to NF-kB
activity, depending on the cell type. Although the NF-kB pathway might be important for stimulating entry into S-phase, it also regulates the
expression of anti-apoptotic genes that contribute to cell survival. The PI-3K–PKB pathway is constitutively active and is essential for
proliferation of Theileria-transformed cells. A direct role in protection against apoptosis, however, is not obvious. Taken together, the activation
of these signalling pathways could help to explain many of the phenotypic changes that have been observed in Theileria-transformed cells
(listed on the right of the figure) that may also contribute to the pathogenesis of Theileriosis.
5/7
Theileria could be highly informative. Transforming
parasite proteins might be expressed on the schizont
surface or secreted into the host cell cytoplasm. It has
recently been reported that Theileria proteins containing
AT hook DNA-binding domains are released from the
parasite and localise to the host cell nucleus [52,53],
potentially modulating the host cell phenotype [54].
Although promising, their role in transformation is still
to be conﬁrmed. For this purpose, the technology to
knock out parasite genes or silence gene expression in
Theileria needs to be developed urgently.
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